Description
Natdac 60mg Tablet is a medication containing Daclatasvir as its active ingredient. Daclatasvir is a potent antiviral medication used in the treatment of chronic Hepatitis C infection. It works by inhibiting the NS5A protein, which is essential for the replication of the Hepatitis C virus (HCV) within liver cells. By blocking this protein, Daclatasvir effectively stops the virus from multiplying, allowing the body’s immune system to clear the infection.
Natdac 60mg Tablet is indicated for use in combination with other antiviral agents for the treatment of chronic Hepatitis C genotypes 1, 2, 3, and 4 in adult patients. The dosage and duration of treatment will be determined by a healthcare professional based on the specific genotype of Hepatitis C, the patient’s liver function, and previous treatment history. It is typically taken orally once daily.
Common side effects associated with Natdac 60mg Tablet may include headache, fatigue, nausea, and insomnia. More serious side effects are rare but can occur. Patients should report any unusual or severe symptoms to their doctor immediately. Storage instructions typically involve keeping the tablets at room temperature, away from moisture and direct light, and out of reach of children.
